| Product Code: ETC8198607 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Malta import of oral hypoglycemic agents (OHAs) in 2024 saw significant contributions from top exporting countries including India, Israel, Ireland, Germany, and Belgium. The market concentration, as indicated by the Herfindahl-Hirschman Index (HHI), remained high in 2024, reflecting a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a robust 10.1%, with a notable growth rate of 29.61% from 2023 to 2024, suggesting a thriving market for OHAs in Malta with strong potential for further expansion.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Oral Hypoglycemic Agents (OHAs) Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, 2021 & 2031F |
3.3 Malta Oral Hypoglycemic Agents (OHAs) Market - Industry Life Cycle |
3.4 Malta Oral Hypoglycemic Agents (OHAs) Market - Porter's Five Forces |
3.5 Malta Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume Share, By Type of Product, 2021 & 2031F |
3.6 Malta Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Malta Oral Hypoglycemic Agents (OHAs) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Malta |
4.2.2 Growing awareness about the importance of managing blood sugar levels |
4.2.3 Technological advancements in the development of oral hypoglycemic agents |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with oral hypoglycemic agents |
4.3.3 Competition from alternative treatments such as insulin therapy |
5 Malta Oral Hypoglycemic Agents (OHAs) Market Trends |
6 Malta Oral Hypoglycemic Agents (OHAs) Market, By Types |
6.1 Malta Oral Hypoglycemic Agents (OHAs) Market, By Type of Product |
6.1.1 Overview and Analysis |
6.1.2 Malta Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Type of Product, 2021- 2031F |
6.1.3 Malta Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Sulfonylureas, 2021- 2031F |
6.1.4 Malta Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Metformin, 2021- 2031F |
6.1.5 Malta Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Thiazolidinediones, 2021- 2031F |
6.1.6 Malta Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Alpha-Glucosidase Inhibitors, 2021- 2031F |
6.2 Malta Oral Hypoglycemic Agents (OHAs) Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 Malta Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Hospital, 2021- 2031F |
6.2.3 Malta Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Malta Oral Hypoglycemic Agents (OHAs) Market Import-Export Trade Statistics |
7.1 Malta Oral Hypoglycemic Agents (OHAs) Market Export to Major Countries |
7.2 Malta Oral Hypoglycemic Agents (OHAs) Market Imports from Major Countries |
8 Malta Oral Hypoglycemic Agents (OHAs) Market Key Performance Indicators |
8.1 Patient adherence rate to oral hypoglycemic agents |
8.2 Number of new product launches in the market |
8.3 Rate of adoption of digital health solutions for diabetes management |
9 Malta Oral Hypoglycemic Agents (OHAs) Market - Opportunity Assessment |
9.1 Malta Oral Hypoglycemic Agents (OHAs) Market Opportunity Assessment, By Type of Product, 2021 & 2031F |
9.2 Malta Oral Hypoglycemic Agents (OHAs) Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Malta Oral Hypoglycemic Agents (OHAs) Market - Competitive Landscape |
10.1 Malta Oral Hypoglycemic Agents (OHAs) Market Revenue Share, By Companies, 2024 |
10.2 Malta Oral Hypoglycemic Agents (OHAs) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |